Psychotropic drugs for treatment of psychoses containing caerulein or the pharmaceutically acceptable salts thereof as effective ingredient, and a method of treatment of psychoses comprising administering said drugs.
This application is a continuation, of now abandoned application Ser. No. 503,646, filed June 15, 1983 which application is a continuation of now abandoned application Ser. No. 293,265, filed Aug. 17, 1981.
Psychosis protecting (PP) nucleic acids and encoded PP peptides and related proteins, and antibodies, anti-idiotype antibodies, and fragments thereto, for treatment, diagnosis and/or research related to the protection from psychosis such as schizophrenia or related disorders, or symptoms thereof, and expression products, compositions and methods therefor, including treatment of schizophrenia and related disorders, as well as transgenic non-human mammals epxressing PP peptide or related protein encoding nucleic acids.
